ArticleEuropean heart journal. Case reports2026
Leadless pacemaker implantation via right jugular approach in a patient with a bicaval valve system: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tricuspid regurgitation in elderly patients with multiple comorbidities presents unique challenges, especially after prior valve interventions and when advanced heart failure symptoms persist. New device-based therapies such as bicaval valve stents (TricValve®) can offer alternatives for patients not suitable for surgery but may complicate pacemaker implantation. Case summary: We report an 85-year-old woman with a history of coronary artery disease, prior valve-in-valve transcatheter aortic valve implantation (TAVI) for a degenerated aortic prosthesis, and permanent atrial fibrillation. She presented with decompensated right heart failure due to severe secondary tricuspid regurgitation, despite optimal medical treatment. After the heart team discussion, surgical repair and transcatheter tricuspid valve replacement were denied for prohibitive risk. A TricValve® system was successfully implanted to treat symptomatic caval reflux.Several days later, she developed complete atrioventricular block with recurrent syncope. A leadless pacemaker (Aveir VR™) was implanted via the right internal jugular vein and navigated safely through the superior cava prosthesis. Device deployment was successful, with no acute procedural complications; however, the patient died shortly thereafter due to pneumonia. Discussion: This case demonstrates the feasibility of leadless pacemaker implantation in the presence of a bicaval valve system and complex, high-risk anatomy. While transvenous pacemaker implantation may still be feasible with a superior vena cava valve prosthesis in place, it can cause unwanted interference, potentially impairing valvular function and increasing the risk of endocarditis compared with leadless pacemaker solutions. However, the findings are limited to acute procedural success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.